Sharif Tabebordbar

Sharif Tabebordbar

Company: Kate Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Optimizing Muscle Targeting 2:00 pm

Evaluating the vectors and promoters currently used for muscular disorders Discussing the challenges and opportunities of current vector discovery approaches Which vectors are showing preclinical promise for the muscle? Is non-viral a viable option?Read more

day: Post-Conference Day

MyoAAV for Targeted Skeletal Muscle Delivery for DMD & XLMTM 1:00 pm

A family of muscle-tropic capsids identified by directed evolution in mice and primates MyoAAV transduction is dependent on integrin heterodimers in mouse and human cells MyoAAV administration at low dose results in therapeutic efficacy in disease models Systemically-administered MyoAAV transduces primate muscles highly efficientlyRead more

day: Post-Conference Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.